News Summary: Merck suspends Tredaptive sales

News Summary: Merck warns physicians to stop prescribing the cholesterol pill Tredaptive

Associated Press

SUSPECT MEDICINE: Merck & Co. is suspending sales of the cholesterol drug Tredaptive after initial results from a study showed that it wasn't effective and could raise the risk of some serious side effects.

WHO'S AFFECTED: The tablets aren't approved in the United States, but they are sold in about 40 countries, including in Europe.

WHAT WENT WRONG: Merck says the side effects were not fatal and fell into several broad categories: blood and lymphatic, gastrointestinal, infections, metabolism, musculoskeletal, respiratory and skin.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You